| Andrea Tieng, Md Inc | |
|
10801 Foothill Blvd Ste 106 Rancho Cucamonga CA 91730-7695 | |
| (909) 255-7200 | |
| (909) 255-7215 |
| Full Name | Andrea Tieng, Md Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 10801 Foothill Blvd Ste 106, Rancho Cucamonga, California |
| Authorized Official Name and Position | Andrea S. Tieng (MD) |
| Authorized Official Contact | 9092557200 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Tieng, Md Inc 10801 Foothill Blvd Ste 106 Rancho Cucamonga CA 91730-7695 Ph: (909) 255-7200 | Andrea Tieng, Md Inc 10801 Foothill Blvd Ste 106 Rancho Cucamonga CA 91730-7695 Ph: (909) 255-7200 |
| NPI Number | 1013276575 |
|---|---|
| Provider Enumeration Date | 05/03/2012 |
| Last Update Date | 01/25/2022 |
| Medicare PECOS PAC ID | 6901058528 |
|---|---|
| Medicare Enrollment ID | O20121206000136 |
News Archive
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial testing a drug treatment for pulmonary hypertension in adults with sickle cell disease nearly one year early due to safety concerns.
The Trump administration quietly invoked the Defense Production Act to force medical suppliers in Texas and Colorado to sell to it first — ahead of states, hospitals or foreign countries.
Researchers worked on mathematical predictions that could predict the safety of reopening schools in the U.S. Their study titled, "Safely Reopening K-12 Schools During the COVID-19 Pandemic," is published preprint at the website medRxiv.
An anti-inflammatory drug called roflumilast could become a new therapeutic strategy for patients with chronic obstructive pulmonary disease (COPD), conclude the results of a randomised trial in this week's issue of The Lancet.
Scientists at Albert Einstein College of Medicine of Yeshiva University have designed a new type of vaccine that could be the first-ever for preventing genital herpes-one of the most common sexually transmitted diseases, affecting some 500 million people worldwide.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013276575 | NPI | - | NPPES |
| 1356528566 | Other | PERSONAL NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | A106477 (California) | Primary |
| Provider Name | Andrea S Tieng |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1356528566 PECOS PAC ID: 9133256860 Enrollment ID: I20100428000624 |
News Archive
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial testing a drug treatment for pulmonary hypertension in adults with sickle cell disease nearly one year early due to safety concerns.
The Trump administration quietly invoked the Defense Production Act to force medical suppliers in Texas and Colorado to sell to it first — ahead of states, hospitals or foreign countries.
Researchers worked on mathematical predictions that could predict the safety of reopening schools in the U.S. Their study titled, "Safely Reopening K-12 Schools During the COVID-19 Pandemic," is published preprint at the website medRxiv.
An anti-inflammatory drug called roflumilast could become a new therapeutic strategy for patients with chronic obstructive pulmonary disease (COPD), conclude the results of a randomised trial in this week's issue of The Lancet.
Scientists at Albert Einstein College of Medicine of Yeshiva University have designed a new type of vaccine that could be the first-ever for preventing genital herpes-one of the most common sexually transmitted diseases, affecting some 500 million people worldwide.
› Verified 1 days ago
News Archive
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial testing a drug treatment for pulmonary hypertension in adults with sickle cell disease nearly one year early due to safety concerns.
The Trump administration quietly invoked the Defense Production Act to force medical suppliers in Texas and Colorado to sell to it first — ahead of states, hospitals or foreign countries.
Researchers worked on mathematical predictions that could predict the safety of reopening schools in the U.S. Their study titled, "Safely Reopening K-12 Schools During the COVID-19 Pandemic," is published preprint at the website medRxiv.
An anti-inflammatory drug called roflumilast could become a new therapeutic strategy for patients with chronic obstructive pulmonary disease (COPD), conclude the results of a randomised trial in this week's issue of The Lancet.
Scientists at Albert Einstein College of Medicine of Yeshiva University have designed a new type of vaccine that could be the first-ever for preventing genital herpes-one of the most common sexually transmitted diseases, affecting some 500 million people worldwide.
› Verified 1 days ago
Carlos R. Vigil, D.o. (a Professional Corporation) Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7974 Haven Ave, Suite 210, Rancho Cucamonga, CA 91730 Phone: 909-941-0661 Fax: 909-948-5577 | |
Bluemedplus Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10970 Arrow Rte Ste 205, Rancho Cucamonga, CA 91730 Phone: 909-446-2304 | |
California Foothills Medical Associates Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8211 Rochester Ave, Suite 101, Rancho Cucamonga, CA 91730 Phone: 909-945-2425 Fax: 909-948-6971 | |
Prohealth Partners A Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8008 Haven Ave Ste 100, Rancho Cucamonga, CA 91730 Phone: 909-483-1236 Fax: 909-344-3910 | |
Mihir K. Sanghvi, M.d., Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5155 Seagreen Ct, Rancho Cucamonga, CA 91739 Phone: 951-323-5598 | |
Deepak Thiagarajan, A Professional Medical Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7974 Haven Ave Ste 210, Rancho Cucamonga, CA 91730 Phone: 909-881-5994 |